Primary |
Hypertension |
15.0% |
Arthritis |
10.0% |
Asthma |
10.0% |
Diabetic Neuropathy |
10.0% |
Muscle Spasms |
10.0% |
Anticoagulant Therapy |
5.0% |
Blood Cholesterol Increased |
5.0% |
Burning Sensation |
5.0% |
Diabetes Mellitus |
5.0% |
Eye Disorder |
5.0% |
Gastrooesophageal Reflux Disease |
5.0% |
Hypersensitivity |
5.0% |
Nail Disorder |
5.0% |
Vitamin Supplementation |
5.0% |
|
Cerebrovascular Accident |
50.0% |
Pharmaceutical Product Complaint |
50.0% |
|
Secondary |
Asthma |
32.0% |
Chronic Obstructive Pulmonary Disease |
24.0% |
Incontinence |
8.0% |
Psoriasis |
8.0% |
Blood Pressure |
4.0% |
Bronchitis Chronic |
4.0% |
Emphysema |
4.0% |
Product Used For Unknown Indication |
4.0% |
Psoriatic Arthropathy |
4.0% |
Rhinorrhoea |
4.0% |
Sleep Disorder |
4.0% |
|
Asthma |
27.3% |
Drug Effect Incomplete |
18.2% |
Drug Hypersensitivity |
9.1% |
Oedema Peripheral |
9.1% |
Pneumonia Fungal |
9.1% |
Pruritus Generalised |
9.1% |
Rhinorrhoea |
9.1% |
Urinary Incontinence |
9.1% |
|
Concomitant |
Product Used For Unknown Indication |
29.4% |
Asthma |
18.5% |
Chronic Obstructive Pulmonary Disease |
13.7% |
Pain |
4.2% |
Hypertension |
4.0% |
Emphysema |
3.9% |
Drug Use For Unknown Indication |
3.7% |
Depression |
2.9% |
Hypersensitivity |
2.8% |
Rheumatoid Arthritis |
2.7% |
Contraception |
1.7% |
Dyspnoea |
1.7% |
Non-small Cell Lung Cancer |
1.6% |
Back Pain |
1.5% |
Cardiac Disorder |
1.5% |
Anxiety |
1.4% |
Gastrooesophageal Reflux Disease |
1.3% |
Prophylaxis |
1.3% |
Bipolar Disorder |
1.2% |
Blood Cholesterol Increased |
1.2% |
|
Dyspnoea |
12.4% |
Product Quality Issue |
10.9% |
Pulmonary Embolism |
7.8% |
Vomiting |
7.0% |
Drug Ineffective |
6.2% |
Rash |
5.4% |
Nausea |
4.7% |
Tremor |
4.7% |
Wheezing |
4.7% |
Pain |
3.9% |
Pneumonia |
3.9% |
Respiratory Failure |
3.9% |
Weight Decreased |
3.9% |
Weight Increased |
3.9% |
Death |
3.1% |
Off Label Use |
3.1% |
Paraesthesia |
3.1% |
Thrombosis |
3.1% |
Fluid Retention |
2.3% |
Lung Infection |
2.3% |
|